600079.SS SHH
Humanwell Healthcare (Group) Co.,Ltd.
1W: +2.4%
1M: +3.0%
3M: +11.3%
YTD: +1.4%
1Y: -9.6%
3Y: -21.7%
5Y: -22.4%
¥19.17 ($2.86)
+0.34 (+1.81%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
#11
of 165
Drug Manufacturers - Specialty & Generic
Technical Signal Map
8 Bullish
1 Neutral
4 Bearish
600079.SS
$31B
Humanwell Healthcare (Group) Co.,Ltd.
BULLISH
+62
1276.HK
$333B
Jiangsu Hengrui Pharmaceuticals Co.,Ltd
BULLISH
+100
000739.SZ
$32B
Apeloa Pharmaceutical Co.,Ltd
BULLISH
+100
000513.SZ
$29B
Livzon Pharmaceutical Group Inc.
BULLISH
+87
600196.SS
$69B
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
BULLISH
+84
600276.SS
$301B
Jiangsu Hengrui Medicine Co., Ltd.
BULLISH
+73
000963.SZ
$49B
Huadong Medicine Co., Ltd
BULLISH
+68
000538.SZ
$90B
Yunnan Baiyao Group Co.,Ltd
BULLISH
+52
3692.HK
$214B
Hansoh Pharmaceutical Group Company Limited
NEUTRAL
0
000999.SZ
$40B
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
LEAN BEAR
-15
002294.SZ
$34B
Shenzhen Salubris Pharmaceuticals Co., Ltd.
BEARISH
-49
000423.SZ
$29B
Dong-E-E-Jiao Co.,Ltd.
BEARISH
-74
002001.SZ
$80B
Zhejiang NHU Company Ltd.
BEARISH
-82
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| 600079.SS Humanwell Healthcare (Group) Co.,Ltd. | $31B | 15.5 | 10.8 | 12.8 | 12.4 | -2.8 | 8 | BULLISH | -9.6 |
| 1276.HK Jiangsu Hengrui Pharmaceuticals Co.,Ltd | $333B | — | — | — | — | — | — | BULLISH | — |
| 000739.SZ Apeloa Pharmaceutical Co.,Ltd | $32B | 37.0 | 12.8 | 11.6 | 11.5 | -17.0 | 6 | BULLISH | 80.6 |
| 000513.SZ Livzon Pharmaceutical Group Inc. | $29B | 17.4 | 12.4 | 19.4 | 16.7 | -8.9 | 3 | BULLISH | -17.8 |
| 600196.SS Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | $69B | 18.8 | 7.1 | 3.8 | 8.2 | 6.2 | 6 | BULLISH | -8.9 |
| 600276.SS Jiangsu Hengrui Medicine Co., Ltd. | $301B | 40.0 | 12.6 | 25.5 | 29.8 | 3.9 | 3 | BULLISH | -22.6 |
| 000963.SZ Huadong Medicine Co., Ltd | $49B | 14.1 | 14.1 | 13.9 | 7.9 | 3.3 | 5 | BULLISH | -34.3 |
| 000538.SZ Yunnan Baiyao Group Co.,Ltd | $90B | 17.3 | 12.8 | 16.5 | 16.2 | 2.3 | 4 | BULLISH | -8.1 |
| 3692.HK Hansoh Pharmaceutical Group Company Limited | $214B | 26.5 | 34.9 | 191.2 | 51.3 | 34.9 | 5 | NEUTRAL | -7.8 |
| 000999.SZ China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | $40B | 12.2 | 14.8 | 18.3 | 8.6 | 12.3 | 7 | LEAN BEAR | -22.4 |
| 002294.SZ Shenzhen Salubris Pharmaceuticals Co., Ltd. | $34B | 50.8 | 7.9 | 7.4 | 12.9 | 14.6 | 6 | BEARISH | -35.8 |
| 000423.SZ Dong-E-E-Jiao Co.,Ltd. | $29B | 16.5 | 17.4 | 70.8 | 30.2 | 9.3 | 5 | BEARISH | -7.8 |
| 002001.SZ Zhejiang NHU Company Ltd. | $80B | 11.1 | 21.9 | 22.3 | 31.9 | 6.2 | 6 | BEARISH | 15.4 |
| 600079.SS Humanwell Healthcare (Group) Co.,Ltd. | $31B | 15.5 | 10.8 | 12.8 | 12.4 | -2.8 | 8 | BULLISH | -9.6 |
| 1276.HK Jiangsu Hengrui Pharmaceuticals Co.,Ltd | $333B | — | — | — | — | — | — | BULLISH | — |
| 000739.SZ Apeloa Pharmaceutical Co.,Ltd | $32B | 37.0 | 12.8 | 11.6 | 11.5 | -17.0 | 6 | BULLISH | 80.6 |
| 000513.SZ Livzon Pharmaceutical Group Inc. | $29B | 17.4 | 12.4 | 19.4 | 16.7 | -8.9 | 3 | BULLISH | -17.8 |
| 600196.SS Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | $69B | 18.8 | 7.1 | 3.8 | 8.2 | 6.2 | 6 | BULLISH | -8.9 |
| 600276.SS Jiangsu Hengrui Medicine Co., Ltd. | $301B | 40.0 | 12.6 | 25.5 | 29.8 | 3.9 | 3 | BULLISH | -22.6 |
| 000963.SZ Huadong Medicine Co., Ltd | $49B | 14.1 | 14.1 | 13.9 | 7.9 | 3.3 | 5 | BULLISH | -34.3 |
| 000538.SZ Yunnan Baiyao Group Co.,Ltd | $90B | 17.3 | 12.8 | 16.5 | 16.2 | 2.3 | 4 | BULLISH | -8.1 |
| 3692.HK Hansoh Pharmaceutical Group Company Limited | $214B | 26.5 | 34.9 | 191.2 | 51.3 | 34.9 | 5 | NEUTRAL | -7.8 |
| 000999.SZ China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | $40B | 12.2 | 14.8 | 18.3 | 8.6 | 12.3 | 7 | LEAN BEAR | -22.4 |
| 002294.SZ Shenzhen Salubris Pharmaceuticals Co., Ltd. | $34B | 50.8 | 7.9 | 7.4 | 12.9 | 14.6 | 6 | BEARISH | -35.8 |
| 000423.SZ Dong-E-E-Jiao Co.,Ltd. | $29B | 16.5 | 17.4 | 70.8 | 30.2 | 9.3 | 5 | BEARISH | -7.8 |
| 002001.SZ Zhejiang NHU Company Ltd. | $80B | 11.1 | 21.9 | 22.3 | 31.9 | 6.2 | 6 | BEARISH | 15.4 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
600079.SS vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F